Prevest Denpro Ltd
Incorporated in 2000, Prevest DenPro Limited is into development and manufacturing of dental materials used for diagnosis, prevention and treatment of dental conditions. Company is heavily export-oriented.
- Market Cap ₹ 457 Cr.
- Current Price ₹ 381
- High / Low ₹ 622 / 318
- Stock P/E 22.3
- Book Value ₹ 104
- Dividend Yield 0.26 %
- ROCE 24.0 %
- ROE 17.8 %
- Face Value ₹ 10.0
Pros
- Company is almost debt free.
Cons
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|
| 56 | 63 | 72 | |
| 36 | 41 | 47 | |
| Operating Profit | 20 | 22 | 25 |
| OPM % | 36% | 35% | 34% |
| 3 | 4 | 5 | |
| Interest | 0 | 0 | 0 |
| Depreciation | 1 | 2 | 2 |
| Profit before tax | 21 | 24 | 28 |
| Tax % | 25% | 25% | 26% |
| 16 | 18 | 20 | |
| EPS in Rs | 13.45 | 15.13 | 17.07 |
| Dividend Payout % | 7% | 7% | 0% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | 14% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | 13% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | -12% |
| 1 Year: | -29% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 18% |
| Last Year: | 18% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|
| Equity Capital | 12 | 12 | 12 |
| Reserves | 77 | 94 | 113 |
| 0 | 0 | 0 | |
| 6 | 7 | 8 | |
| Total Liabilities | 95 | 113 | 133 |
| 27 | 27 | 27 | |
| CWIP | 0 | 0 | 0 |
| Investments | 2 | 5 | 9 |
| 66 | 81 | 98 | |
| Total Assets | 95 | 113 | 133 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|
| 12 | 15 | 15 | |
| -2 | -1 | -2 | |
| -0 | -1 | -1 | |
| Net Cash Flow | 10 | 12 | 12 |
| Free Cash Flow | 8 | 13 | 13 |
| CFO/OP | 81% | 93% | 87% |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|
| Debtor Days | 53 | 44 | 44 |
| Inventory Days | 168 | 240 | 239 |
| Days Payable | 32 | 48 | 55 |
| Cash Conversion Cycle | 189 | 236 | 229 |
| Working Capital Days | 79 | 82 | 135 |
| ROCE % | 25% | 24% |
Insights
In beta| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Number of Countries Exported To Countries (approx.) |
|
||||||
| Number of Dealers in India Dealers (approx.) |
|||||||
| Number of Overseas Agents Overseas Agents (approx.) |
|||||||
| Number of Permanent Employees Employees |
|||||||
| Capacity Utilization % |
|||||||
| Installed Capacity MT per annum |
|||||||
| Domestic Revenue Share % of Revenue from Operations |
|||||||
| R&D Expenditure (Percentage of Turnover) % ・Standalone data |
|||||||
Extracted by Screener AI
Documents
Announcements
-
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
2d - Regulation 74(5) compliance certificate for quarter ended June 30, 2026; entire shareholding remains in demat form.
-
Announcement under Regulation 30 (LODR)-Earnings Call Transcript
2 Jul - Transcript for Earning''s call held on 29th June, 2026
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
29 Jun - Audio recording of June 29, 2026 earnings call for FY2026 performance shared.
-
Announcement under Regulation 30 (LODR)-Investor Presentation
27 Jun - Investor Presentation to be made to Analysts/Investor on the Financial Results for financial year ended March 31, 2026
- Closure of Trading Window 27 Jun
Annual reports
Concalls
-
Jul 2026Transcript PPT REC
-
Nov 2025Transcript PPT
-
Jun 2025Transcript PPT
-
Feb 2025TranscriptAI SummaryPPT
-
Nov 2024Transcript PPT
-
Aug 2024TranscriptAI SummaryPPT
-
Jun 2024Transcript PPT
-
Feb 2024Transcript PPT
-
Nov 2023Transcript PPT
-
Aug 2023Transcript PPT
-
May 2023Transcript PPT
-
Feb 2023Transcript PPT
-
Nov 2022Transcript PPT
-
Aug 2022Transcript PPT
-
Aug 2022TranscriptAI SummaryPPT
-
May 2022Transcript PPT
-
Feb 2022Transcript PPT
-
Feb 2022TranscriptPPT
-
Dec 2021TranscriptPPT
Product Portfolio[1]
The company offers over 100 dental products across:
a) Restorative Materials:
Cavity restoration solutions.
b) Endodontic Solutions:
Root canal treatment
materials.
c) Preventive Care:
Post-extraction and decay
prevention products.
d) Orthodontic Adhesives:
Bonding solutions for braces
and aligners.
e) Impression Materials & Cements:
Impression and cementation products.